Skip to main content

Molecular considerations of primary biliary cirrhosis

  • Chapter
Primary Biliary Cirrhosis
  • 78 Accesses

Abstract

Primary biliary cirrhosis is a destructive autoimmune disease of the intrahepatic bile ducts characterized by inflammation of the portal triads, fibrosis and the presence of antimitochondrial antibodies1,2. The typical patient with PBC is 40–60 years of age, female, with a clinical presentation of lethargy, pruritus that is debilitating and persistent, or mild jaundice. PBC is virtually the only autoimmune disease never reported in a pediatric population, and is uncommon before age 30, after which the incidence gradually rises with age. Increasingly, however, patients are being detected in the presymptomatic stage as a result of multiphasic laboratory screening tests because of elevations in serum alkaline phosphatase. The pathological changes in PBC are best thought of as an autoimmune cholangiolitis and the common scheme of histological grading of severity recognizes four stages3.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kaplan M M, Knox TA. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate. Gastroenterology 1991;101:1332–8.

    PubMed  CAS  Google Scholar 

  2. Gershwin ME, Mackay IR. Primary biliary cirrhosis:paradigm or paradox for autoimmunity. Gastroenterology 1991;100:822–33.

    PubMed  CAS  Google Scholar 

  3. Dickson ER, Fleming CR, Ludwig J. Primary Hilary cirrhosis. Prog Liv Dis 1979;6:487–502.

    CAS  Google Scholar 

  4. James SP, Hoofnagle JH, Strober W, et al. NIH conference:Primary biliary cirrhosis:a model autoimmune disease. Ann Intern Med 1983;99:500–12.

    PubMed  CAS  Google Scholar 

  5. Coppel RL, Gershwin ME. Primary biliary cirrhosis:The molecule and the mimic. Immunol Rev 1995;144:17–49.

    Article  PubMed  CAS  Google Scholar 

  6. Leung PS, Van de Water J, Coppel RL, et al. Molecular characterization of the mitochondrial autoantigens in primary biliary cirrhosis. Immunol Res 1991;10:518–27.

    Article  PubMed  CAS  Google Scholar 

  7. Leung PS, Krams S, Munoz S, et al. Characterization and epitope mapping of human monoclonal antibodies to PDC-E2, the immunodominant autoantigen of primary biliary cirrhosis. J Autoimmun 1992;5:703–18.

    Article  PubMed  CAS  Google Scholar 

  8. Krams SM, Surh CD, Coppel RL, et al. Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis. Hepatology 1989;9:411–16.

    Article  PubMed  CAS  Google Scholar 

  9. Lever E, Balasubramanian K, Condon S, et al. Primary biliary cirrhosis associated with ulcerative colitis. Am J Gastroenterol 1993;88:945–7.

    PubMed  CAS  Google Scholar 

  10. Van, de Water J, Ansari A, Prindiville T et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995;181:723–33.

    Article  PubMed  Google Scholar 

  11. Karisson-Parra A, Nyberg A, Totterman TH, et al. Primary biliary cirrhosis-phenotypic characterization of immunocompetcnt cells in peripheral blood and liver tissue. Uppsala J Med Sci 1984;89:254–65.

    Article  Google Scholar 

  12. Bjorkland A, Festin R, Mendel-Hartvig I, el al. Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis:increase in activated T and natural killer cells and recruitment of primed memory T cells. Hepatology 1991;13:1106–11.

    PubMed  CAS  Google Scholar 

  13. Bjorkland A, Totterman TH. Is primary biliary cirrhosis an autoimmune disease? Scand J Gastroenterol Suppl 1994;204:32–9.

    Article  PubMed  CAS  Google Scholar 

  14. Van, de Water J, Ansari AA, Surh CD et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 1991;146:89–94.

    PubMed  Google Scholar 

  15. Lohr H, Fleischer B, Gerken G, et al. Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopcs and the pyruvate dehydrogenase complex. J Hepatol 1993;18:322–7.

    Article  PubMed  CAS  Google Scholar 

  16. Leon MP, Spickett G, Jones DE, et al. CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clin Exp Immunol 1995;99:233–9.

    Article  PubMed  CAS  Google Scholar 

  17. Vierling JM. Immune disorders of the liver and bile duct. Gastroenterol Clin N Am 1992;21:427–49.

    CAS  Google Scholar 

  18. Weaver GA, Franck WA, Streck WF. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 1982;306:1235–6.

    Article  PubMed  CAS  Google Scholar 

  19. Wong PY, Portmann B, O’Grady JG, et al. Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression. J Hepatol 1993;17:284–7.

    Article  PubMed  CAS  Google Scholar 

  20. Neuberger J, Portmann B, Macdougall BR, et al. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 1982;306:1–4.

    Article  PubMed  CAS  Google Scholar 

  21. Dietze O, Vogel W, Margreiter R, et at. Early recurrence of primary biliary cirrhosis after liver transplantation. Gastroenterology 1990;98:1106–7.

    Article  PubMed  CAS  Google Scholar 

  22. Hart J, Busuttil RW, Lewin KJ. Disease recurrence following liver transplantation. Am J Surg Pathol 1990;1:79–91.

    Google Scholar 

  23. Van, de Water J, Gershwin ME, Leung P et al. The autoepitope of the 74-k D mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 1988;167:1791–9.

    Article  PubMed  Google Scholar 

  24. Van, de Water J, Cooper A, Surh CD et al. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med 1989;320:1377–80.

    Article  PubMed  Google Scholar 

  25. Coppel RL, McNeilage LJ, Surh CD, et al. Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis:dihydrolipoamide acetyltransferase. Proc Natl Acad Sci USA 1988;85:7317–21.

    Article  PubMed  CAS  Google Scholar 

  26. Fussey SP, Guest JR, James OF, et al. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 1988;85:8654–8.

    Article  PubMed  CAS  Google Scholar 

  27. Mackay IR, Gershwin ME. Primary biliary cirrhosis:current knowledge, perspectives, and future directions. Semin Liv Dis 1989;9:149–57.

    Article  CAS  Google Scholar 

  28. Mackay IR, Gershwin ME. Primary biliary cirrhosis:considerations on pathogenesis based on identification of the M2 autoantigens. Scmin Immunopathol 1990;12:101–19.

    CAS  Google Scholar 

  29. Surh CD, Coppel R, Gershwin ME. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope. J Immunol 1990;144:3367–74.

    PubMed  CAS  Google Scholar 

  30. Sundin U. Antibody binding and inhibition of pyruvate dehydrogenase (PDH) in sera from patients with primary biliary cirrhosis. Clin Exp Immunol 1990;81:238–43.

    Article  PubMed  CAS  Google Scholar 

  31. Uibo R, Mackay IR, Rowley M, et al. Inhibition of enzyme function by human autoantibodies to an autoantigen pyruvate dehydrogenase E2:different epitope for spontaneous human and induced rabbit autoantibodies. Clin Exp Immunol 1990;80:19–24.

    Article  PubMed  CAS  Google Scholar 

  32. Van, de Water J, Fregeau D, Davis P et al. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol 1988;141:2321–4.

    PubMed  Google Scholar 

  33. Fregeau DR, Davis PA, Danner DJ, et al. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex. J Immunol 1989;142:3815–20.

    PubMed  CAS  Google Scholar 

  34. Fregeau DR, Prindiville T, Coppel RL, et al. Inhibition of alpha-ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognizing dihydrolipoamide succinyltransferase in primary biliary cirrhosis. Hepatology 1990;11:975–81.

    Article  PubMed  CAS  Google Scholar 

  35. Fregeau DR, Roche TE, Davis PA, et al. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for El alpha, a non-lipoic acid containing mitochondria) enzyme. J Immunol 1990;144:1671–6.

    PubMed  CAS  Google Scholar 

  36. Berg PA, Klein R. Autoantibodies in primary biliary cirrhosis. Springer Semin Immunopathol 1990;12:85–99.

    Article  PubMed  CAS  Google Scholar 

  37. Gershwin ME, Mackay IR, Sturgcss A, et al. Identification and specificity of a cDNA encoding the 70 kd mitochondria) antigen recognized in primary biliary cirrhosis. J Immunol 1987;138:3525–3I.

    PubMed  CAS  Google Scholar 

  38. Surh CD, Roche TE, Danner DJ, et al. Antimitochondrial autoantibodies in primary biliary cirrhosis recognize crossreactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex. Hepatology 1989;10:127–33.

    Article  PubMed  CAS  Google Scholar 

  39. Yeaman SJ, Fussey SP, Danner DJ, et al. Primary biliary cirrhosis:identification of two major M2 mitochondrial autoantigens. Lancet 1988;1:1067–70.

    Article  PubMed  CAS  Google Scholar 

  40. Moteki S, Leung P, Dickson E, et al. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex. Hepatology 1996;23 (3):436–44.

    Article  PubMed  CAS  Google Scholar 

  41. Imai H, Fritzler MJ, Neri R, et al. Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90/hUBF autoantigens. Mol Biol Rep 1994;19:115–24.

    Article  PubMed  CAS  Google Scholar 

  42. Ghadiminejad I, Baum H. Evidence for the cell-surface localization of antigens crossreacting with the ‘mitochondrial antibodies’of primary hiliary cirrhosis. Hepatology 1987;7:743–9.

    Article  PubMed  CAS  Google Scholar 

  43. Surh CD, Cooper AE, Coppel RL, et al. The predominance of IgG3 and 1gM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis. Hepatology 1988;8:290–5.

    Article  PubMed  CAS  Google Scholar 

  44. Outschoorn I, Rowley MJ, Cook AD, et al. Subclasses of immunoglobulins and autoantibodies in autoimmune diseases. Clin Immunol Immunopathol 1993;66:59–66.

    Article  PubMed  CAS  Google Scholar 

  45. Surh CD, Danner DJ, Ahmed A, et al. Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched-chain alpha-keto acid dehydrogenase dihydrolipoamide acyltransfcrase, the 52 kDa mitochondrial autoantigen. Hepatology 1989;9:63–8.

    Article  PubMed  CAS  Google Scholar 

  46. Leung PSC, Chuang DT, Wynn RM, et al. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology 1995;22:505–13.

    PubMed  CAS  Google Scholar 

  47. Yeaman SJ. The mammalian 2-oxoacid dehydrogenases:a complex family. Trends Biochcm Sci 1986;11:293–7.

    Article  CAS  Google Scholar 

  48. Van, de Water J, Turchany J, Leung PS et al. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule crossreactive with pyruvate dehydrogenase complex-E2. J Clin Invest 1993;91:2653–64.

    Article  PubMed  Google Scholar 

  49. Joplin R, Lindsay JG, Hubscher SG, et al. Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis:an immunohistochemical study. Hepatology 1991;14:442–7.

    Article  PubMed  CAS  Google Scholar 

  50. Joplin R, Lindsay JG, Johnson GD, et al. Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in PBC. Lancet 1992;339:93–4.

    Article  PubMed  CAS  Google Scholar 

  51. Joplin R, Wallace LL, Johnson GD, et al. Subccllular localization of pyruvate dehydrogenase dihydrolipoamide acetyltransferase in human intrahepatic biliary epithelial cells. J Pathol 1995;175.

    Google Scholar 

  52. Szostecki C, Guldner HH, Will H. Autoantibodies against ‘nuclear dots’in primary biliary cirrhosis. Semin Liv Dis 1997;17:71–8.

    Article  CAS  Google Scholar 

  53. Courvalin JC, Worman HJ. Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin Liv Dis 1997;17:79–90.

    Article  CAS  Google Scholar 

  54. Miyachi K, Shibata M, Onozuka Y, et al. Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Mol Biol Rep 1996;23:227–34.

    Article  PubMed  CAS  Google Scholar 

  55. Feistauer SM, Penner E, Mayr WR, et al. Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis. Hepatology 1997;25:1343–5.

    Article  PubMed  CAS  Google Scholar 

  56. Cha S, Leung PS, Coppel RL, et al. Heterogeneity of combinatorial human autoantibodies against PDC-E2 and biliary epithelial cells in patients with primary biliary cirrhosis. Hepatology 1994;20:574–83.

    Article  PubMed  CAS  Google Scholar 

  57. Pascual V, Cha S, Gershwin ME, et al. Nucleotide sequence analysis of natural and combinatorial anti-PDC-E2 antibodies in patients with primary biliary cirrhosis. Recapitulating immune selection with molecular biology. J Immunol 1994;152:2577–85.

    PubMed  CAS  Google Scholar 

  58. Tsuneyama K, Van de Water J, Nakanuma Y, et al. Human combinatorial autoantibodies and mouse monoclonal antibodies to PDC-E2 produce abnormal apical staining of salivary glands in patients with coexistent primary biliary cirrhosis and Sjögren’s syndrome. Hepatology 1994;20:893–8.

    Article  PubMed  CAS  Google Scholar 

  59. Joplin RE, Johnson GD, Matthews JB, et cd. Distribution of pyruvate dehydrogenase dihydrolipoamide acetyllransferase (PDC-E2) and another mitochondria) marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis. Hepatology 1994;19:1375–80.

    Article  PubMed  CAS  Google Scholar 

  60. Cha S, Leung PS, Gershwin ME, et al. Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis. Proc Natl Acad Sci USA 1993;90:2527–31.

    Article  PubMed  CAS  Google Scholar 

  61. Tsuneyama K, Van de Water J, Leung PSC, et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BBI/B7 expression. Hepatology 1995;21:1031–7.

    PubMed  CAS  Google Scholar 

  62. Surh CD, Ahmed-Ansari A, Gershwin ME. Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondria) autoantigen of primary biliary cirrhosis. J Immunol 1990;144:2647–52.

    PubMed  CAS  Google Scholar 

  63. McNeilage U, Umapathysivam K, Macmillan G et al. Definition of a discontinuous immunodominant epitope at the NH2 terminus of the La/SS-B ribonucleoprotein autoantigen. J Clin Invest 1992;89:1652–6.

    Article  PubMed  CAS  Google Scholar 

  64. Ben-Chetrit E. The molecular basis of the SSA/Ro antigens and the clinical significance of their autoantibodies. Br J Rheumatol 1993;32:396–402.

    Article  PubMed  CAS  Google Scholar 

  65. Frank MB, McCubbin VR, Heldermon C. Expression and DNA binding of the human 52 kDa Ro/SSA autoantigen. Biochem J 1995;305:359–62.

    PubMed  CAS  Google Scholar 

  66. Huff JP, Roos G, Peebles CL, et al. Insights into native epitopes of proliferating cell nuclear antigen using recombinant DNA protein products. J Exp Med 1990;172:419–29

    Article  PubMed  CAS  Google Scholar 

  67. Troster H, Metzger TE, Semsei I, et al. One gene, two transcripts:isolation of an alternative transcript encoding for the autoantigen La/SS-B from a cDNA library of a patient with primary Sjögren’s syndrome. J Exp Med 1994;180:2059–67.

    Article  PubMed  CAS  Google Scholar 

  68. Talal N, Garry RF, Schur PH, et al. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest 1990;85:1866–71.

    Article  PubMed  CAS  Google Scholar 

  69. O’Brien RM, Cram DS, Coppel RL, et al. T-cell epitopes on the 70-kDa protein of the (U I)RNP complex in autoimmune rheumatologic disorders. J Autoimmun 1990;3:747–57.

    Article  PubMed  Google Scholar 

  70. McNeilage U, Macmillan EM, Whittingham SF. Mapping of epitopes on the La(SS-B) autoantigen of primary Sjögren’s syndrome:identification of a crossreactive epitope. J Immunol 1990;145:3829–35.

    PubMed  CAS  Google Scholar 

  71. Bassendine MF, Fussey SPM, Mutimer DJ, et al. Identification and characterization of four M2 mitochondria) autoantigens in primary biliary cirrhosis. Semin Liv Dis 1989;9:124–31.

    Article  CAS  Google Scholar 

  72. Morreale M, Tsirigotis M, Hughes MD, et al. Significant bacteriuria has prognostic significance in primary biliary cirrhosis. J Hepatol 1989;9:149–58.

    Article  PubMed  CAS  Google Scholar 

  73. Flannery GR, Burroughs AK, Butler P, et al. Antimitochondrial antibodies in primary biliary cirrhosis recognize both specific peptides and shared epitopes of the M2 family of antigens. Hepatology 1989;10:370–4.

    Article  PubMed  CAS  Google Scholar 

  74. Fusconi M, Baum H, Caselli A, et al. Demonstration of peptide-specific and cross-reactive epitopes in proteins reacting with antimitochondrial antibodies of primary biliary cirrhosis. J Hepatol 1992;15:162–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Gershwin, M.E., Migliaccio, C.T., Van De Water, J., Coppel, R.L. (1998). Molecular considerations of primary biliary cirrhosis. In: Lindor, K.D., Heathcote, E.J., Poupon, R. (eds) Primary Biliary Cirrhosis. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4884-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4884-9_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6047-9

  • Online ISBN: 978-94-011-4884-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics